Conference Cancellation Notice:
As a precautionary measure with concerns around the Novel Coronavirus (COVID-19) outbreak and in line with guidance from international health organizations, IMN has been working with our teams, clients and suppliers around the world to monitor the impact of the virus. It is as part of this review and the development of the situation that has led us to cancel IC3 - The 2nd Institutional Capital & Cannabis Conference (Europe) scheduled for June 24.
We apologize for any inconvenience caused, but as always, the safety of our participants, community and staff are our priority and we feel this is the best option for this event. Our thoughts are with those in impacted areas.
We will announce future dates as soon as they become available.
If you have any questions or concerns then please raise this with your IMN representative or email the team at email@example.com
The IMN Team
IMN is excited to announce our continued partnership with Prohibition Partners, Europe’s leading provider of market and strategic insights into the European legal cannabis markets. IMN and Prohibition Partners will co-host the second annual Institutional Capital & Cannabis Conference Europe
(IC3 Europe), June 24, in London.
With over double the population of the US and Canada combined, Europe is expected to become the largest legal cannabis market in the world, within the next five to ten years. Some analysts are estimating that the European legal cannabis market will be worth €125 billion by 2028. The multijurisdictional nature of Europe makes it a complex market but lessons can be learned from regulated markets as industry players look to take advantage of the opportunities that exist.
IMN’s IC3 forums are a meeting place for investors who wish to invest or learn more about this exciting and high-growth new asset class, cannabis companies and investment funds who are looking to raise money or showcase their products, and professional service providers who facilitate these groups doing business.
Our US conferences have earned a reputation for quality content, expert speakers, and a high representation of institutional investors. Previous IC3 participants include leading cannabis brands Canndescent, MedMen, MedReleaf, Flow Kana, Tikun Olam
and funds such as Privateer Holdings (Tilray, Marley Natural), Casa Verde (Eaze), Gotham Green Partners (Cronos), Merida Capital (KushCo)
and a number of ex-Wall Street professionals turned private investors.
IMN is excited to bring this one-of-kind forum aimed at sophisticated investors seeking alternative asset classes and portfolio diversification to the UK this June.